In the last trading session, 1,213,813 shares of the Fennec Pharmaceuticals Inc. (NASDAQ:FENC) were traded, and its beta was 0.1. Most recently the company’s share price was $6.93, and it changed around $0.94 or 0.16% from the last close, which brings the market valuation of the company to $179.79 Million. FENC currently trades at a discount to its 52-week high of $10.67, offering almost -53.97% off that amount. The share price’s 52-week low was $4.8, which indicates that the current value has risen by an impressive 30.74% since then. We note from Fennec Pharmaceuticals Inc.’s average daily trading volume that its 10-day average is 125.33 Million shares, with the 3-month average coming to 82.61 Million.
Fennec Pharmaceuticals Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 1.5. If we narrow it down even further, the data shows that none out of 2 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended FENC as a Hold, whereas 2 deemed it a Buy, and no one rated it as Underweight. Fennec Pharmaceuticals Inc. is expected to report earnings per share of -$0.12 for the current quarter.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Trading Information
Instantly FENC has showed a green trend with a performance of 15.69% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $6.97- on Tuesday, Apr 06 increased the stock’s daily price by 0.57%. The company’s shares are currently down -0.07% year-to-date, but still up 0.1159 over the last five days. On the other hand, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) is -0.06% down in the 30-day period. We can see from the shorts that 1Million shares have been sold at a short interest cover period of 0.01 day (s).
The consensus price target as assigned by Wall Street analysts is $12, which translates to bears needing to increase their stock price by 73.16% from its current value. Analyst projections state that FENC is forecast to be at a low of $11 and a high of $13. In order for the stock price to hit the forecast high, the stock would need to surge +87.59% from its current level, while the stock would need to crash 58.73% from its current level to reach the projected low.
Fennec Pharmaceuticals Inc. (FENC) projections and forecasts
Fennec Pharmaceuticals Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +15.69 percent over the past six months and at a -250% annual growth rate that is well below the industry average of 17.3%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +36.8% in revenue this quarter, and will report an increase of 42.9% in the next quarter. The year-over-year growth rate is expected to be 60452.9%, up from the previous year.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -65.9%. Fennec Pharmaceuticals Inc. earnings are expected to decrease by -19% in 2021, but the outlook is negative 0% per year for the next five years.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 16.94% of Fennec Pharmaceuticals Inc. shares, and 56.53% of them are in the hands of institutional investors. The stock currently has a share float of 68.06%. Fennec Pharmaceuticals Inc. stock is held by 80 institutions, with Southpoint Capital Advisors Lp being the largest institutional investor. By Dec 30, 2020, it held 15.68% of the shares, which is about 4.08 Million shares worth $30.38 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Sonic Fund II, L.P., with 9.36% or 2.43 Million shares worth $18.13 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 30, 2020. The former held 1120000 shares worth $8.34 Million, making up 4.31% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 526.55 Thousand shares worth around $3.85 Million, which represents about 2.02% of the total shares outstanding.